We retrospectively identified 163 patients with inoperable NSCLC and sufficient tumor tissue for ERCC1 analysis, who had received carboplatin and gemcitabine as first-line treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback